Vol. 3 Issue 3 (2010)

Обложка журнала

PDF downloadDownload the whole Issue

Editorial P.4

LEADING ARTICLE

80th anniversary of medikal service of the Ministry of Internal Affairs of Tatarstan Republic. Health care of those, who guards law and order. M.V. Potapova, L.R. Ginyatoullina, R.R. Shaymardanov P.5

The peculiarities of forming the quality management system and managing risks in departmental health care. M.V. Potapova, L.F. Sabirov P.8

ORIGINAL ARTICLES

Evaluation of rationality of antiseptic agents application in a multiple-discipline hospital using the АВС/ VEN analysis. Z.B. Abdоulgalimova, S.N. Egorova P.11

Use of scalene assays for estimation of неаrt rate variability at patients with the unstable atrial fibrilation and the ventricular tachycardia. N.B. Amirov, E.V. Choukhnin P.13

Calcium hydroxide in the treatment of destructive forms of periodontitis with subsequent rehabilitation. V.V. Gilyazeva, A.I. Shaikhoutdinova P.18

Vasoactive function of endothelium in patients with copd and opportunities of its medicamental correction. N.A. Kоuzоubova, A.Yu. Gichkin, V.E. Perley P.21

Neurovegetatic regulation of cardiorespiratory functional system at patients with bronchial asthma. V.N. Marchenko, V.I. Trofimov, V.A. Alexandrin, G.B. Fedoseyev P.26

Interstitial lung diseases in pulmonological and rheumatological hospitalized patients. A.P. Rebrov, E.Yu. Ponomareva, E.E. Arkhangelskaya P.30

The evolution of the functional tests in patients with chronic obstructive pulmonary disease three months after comprehensive vaccination against pneumococcus, haemophilus influenzae type b and influenza. A.D. Protasov, A.V. Zhestkov, M.P. Kostinov, A.A. Ryzhov P.35

REVIEWS

Up-to-date standarts of eradication therapy. Аre all the questions answered? R.A. Abdoulkhakov, S.R. Abdoulkhakov P.40

LECTURES

Tubulointerstitial nephritis. O.N. Sigitova, E.V. Arkhipov P.45

BRIEF ARTICLES

Experience of combined (with roentgenotherapy) treatment of lymphorrhea in the groin after arterial reconstruction. I.I. Kamalov, I.V. Gоulyayeva, R.R. Akhmadeyev P.50

FOR GENERAL PRACTITIONER

Depression and female health. N.S. Volchkova, S.F. Soubchankoulova, A.F. Soubchankoulova P.52

CLINICAL CASE

Clinical case of the severe flu at the pregnant woman, complicated by pneumonia development. R.P. Gouslyakova, I.R. Galimova, A.A. Vizel, I.G. Salikhov, A.A. Hasanov, V.I. Ilyinskiy, A.A. Vanyushin, P.V. Ilyin, A.G. Skripina P.56

Clinical case of follow-up of patient with gout and metabolic syndrome. V.B. Zakirova, G.S. Galyautdinov, E.V. Skryabina, A.N. Gaifoullina, A.I. Gainetdinov P.60

Augmentation mammoplasty. S.A. Obydennov P.63

Wolff—Parkinson—White Syndrome in cardiology practice (demonstration of clinical case). R.G. Saifoutdinov, E.V. Pak, A.R. Gilyazova, E.F. Roubanova, R.S. Nasyboullina P.68

Wegeners granulematosis (clinical case in practice). O.N. Sigitova, E.I. Bikmoukhammetova, A.R. Bogdanova P.73

MEDICINE HISTORY

Evolution of pediatric surgery and urology in Kazan. A.A. Akhounzyanov P.77

____

LEADING ARTICLE

PDF download80th anniversary of medikal service of the Ministry of Internal Affairs of Tatarstan Republic. Health care of those, who guards law and order

M.V. Potapova, L.R. Ginyatoullina, R.R. Shaymardanov

 

PDF downloadThe peculiarities of forming the quality management system and managing risks in departmental health care

M.V. Potapova, L.F. Sabirov

 

ORIGINAL ARTICLES

PDF downloadEvaluation of rationality of antiseptic agents application in a multiple-discipline hospital using the АВС/ VEN analysis

Z.B. Abdоulgalimova, S.N. Egorova

Abstract. The rationality of industrial and chemist's manufacture antiseptic agents application in a multiple-discipline hospital working according to offcial record system was evaluated using the AВС/VEN analysis. Highest expenses were established for the formulations in the group of chemist's manufacture antiseptics.

Key words: antiseptic agent, offcial record system, pharmacoeconomics, formulation.

References

  1. Respublikanskij formuljarnyj spravochnik: torgovye nazvanija, lekarstvennye formy i gruppovaja prinadlezh¬nost' lekarstvennyh sredstv / pod red. F.F. Jarkaevoj. — 5-e izd. — Kazan': Medicina, 2009. — 328 s.
  2. Formuljarnaja sistema: metodicheskoe rukovodstvo po raz¬rabotke, vnedreniju i podderzhaniju / pod red. N.I. Galiul-lina, R.S. Safiullina, L.E. Ziganshinoj [i dr.]. — Kazan', 2005. — 44 s.

 

PDF downloadUse of scalene assays for estimation of неаrt rate variability at patients with the unstable atrial fibrilation and the ventricular tachycardia

N.B. Amirov, E.V. Choukhnin

Аbstract. An estimation of parametres HRV at an unstable ventricular tachycardia and fbrillation of auricles at use of scalene assays. We had been surveyed 87 persons, from which 48 persons (51±10 years), have made control group. The group with an unstable ventricular tachycardia, according to daily record of electrocardiogram (3 and more ventricular complexes successively), has included 16 persons (57±7 years). The group with unstable fbrillation of auricles (3 and more supraventricular complexes successively) has made 23 persons (58±8 years). Research was spent on a complex of daily monitoring of an electrocardiogram «DNK and K» with the program of variability of a heart rate by means of what defned: the heart beats at night (the minimum HB) and at load height (the maximum HB), depression ST, parametres VLF, LF, HF (for three-minute intervals of time) — both in rest, and on a load, a root-mean-square deviation (SDNN) for days. The program of exercise stresses included step lifting on 2, 3, 5, and 9 foors with rest possibility necessarily. For an estimation of features of psycho-emotional reaction projective colour Lusher test (preference certain colour shades) was carried out. Disturbances of vegetative regulation are most expressed in group VT (both sympathetic, and parasympathetic reaction), in the group of AF is rising of a parasympathetic tonus, reaction takes place — is not broken. Differences of psycho-emotional reaction, according to Lusher test , in analyzed groups are not present. It is necessary to use scalene assays for the standardised estimation of parametres HRV.

Key words: Heart rate variability, ventricular tachycardia, atrial fbrillation, scalene assays.

 

References

  1. Kuljamin, A.I. Osobennosti variabel'nosti serdechnogo rit¬ma u bol'nyh s zheludochkovymi aritmijami / A.I. Kuljamin, E.Z. Goluhova, M.G. Adamjan, I.M. Dmitrieva // Komp'juternaja jelektrokardiografija na rubezhe stoletij HH—HHI. Mezhdu¬narodnyj simpozium: tez. dokl. — M., 1999. — S. 183.
  2. Rjabykina G, V. Variabel'nost' ritma serdca: monografija / G.V. Rjabykina, A.V. Sobolev. — M.,1998.
  3. Shljahto, E.V. Variabel'nost' serdechnogo ritma kak ot¬razhenie vegetativnogo disbalansa u bol'nyh s ostrym infarktom miokarda, oslozhnivshimsja narushenijami ritma / E.V. Shljahto, A.V. Panov, N.Ju. Binatova, F.G. Mihajlov // Variabel'nost' serdechnogo ritma: teoreticheskie aspekty i prakticheskoe primenenie. Mezhdunarodnyj simpozium: tez. dokl. — Izhevsk, 1996. — S. 67—68.
  4. Andresen, D. Heart rate variability preceding onset of atrial fbrillation / D. Andresen, T. Bruggemann // J.Cardiovasc. Electrophysiol. — 1998. — № 9, suppl. 8. — P. 526—529.
  5. Berger, R.D. Transfer function analysis of autonomic regulation: I — The canine atrial rate response. / R.D. Berger, J.P. Saul, R.J. Cohen // Am. J. Physiol. — 1989. — Vol. 256. — P. H142—152.
  6. Chen, Y.J. Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fbrillation / Y.J. Chen, S.A. Chen, C.T. Tai // J. Am. Coll. Cardiol. — 1998. — № 32(3). — R. 732—738.
  7. Coccagna, G. Paroxysmal atrial fbrillation in sleep / G. Coc-cagna, A. Capucci, S. Bauleo // Sleep 1997. — № 20(6). — R. 396—398.
  8. Cripps, T.R. Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method. / T.R. Cripps, M. Malik, T.G. Farelli // Br. Heart J. — 1991. — Vol. 65. — R. 14—19.
  9. Dimmer, C. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting / C. Dimmer, R. Tavernier, N. Gjorgov // Am. J. Cardiol. — 1998. — Vol. 1, № 82(1). — R. 22—25.
  10. Fioranelli, M. Analysis of heart rate variability fve minutes before the onset of paroxysmal atrial fbrillation / M. Fioranelli, M. Piccoli, G.M. Mileto // Pacing. Clin. Electrophysiol. — 1999. — № 22(5). — R. 743—749.
  11. Gallagher, M.M. Evolution of changes in the ventricular rhythm during paroxysmal atrial fbrillation / M.M. Gallagher, K. Hnatkova, F.D. Murgatroyd // Pacing. Clin. Electrophysiol. — 1998. — № 21(11), rt. 2. — R. 2450—2454.
  12. Herweg, B. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fbrillation / B. Herweg, P. Dalal, B. Nagy, P. Schweitcer // Am. J. Cardiol. — 1998. — Vol. 1, № 82(7). — R. 869—874.
  13. Huang, J.L. Changes of autonomic tone before the onset of paroxysmal atrial fbrillation / J.L. Huang, Z.C. Wen, W.L. Lee // Int. J. Cardiol. — 1998. — Vol. 30, № 66(3). — R. 275—283.
  14. Huikuri, H.V. Impaired low-frequency oscillation of heart rate in patients with prior acute myocardial infarction and life-threa¬tening arrhythmias / H.V. Huikuri, M.J. Koistinen, S. Yli-Mayry // Am. J. Cardiol. — 1995. — Vol. 1, № 76 (1). — R. 56—60.
  15. Kleiger, R.E. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction / R.E. Kleiger, J.P. Miller, J.T. Bigger, A.J. Moss; the Multi-center Post-Infarction Research Group // Am. J. Cardiol. — 1987. — Vol. 59. — R. 256—262.
  16. Reinhardt, L. Reduced beat-to-beat changes of heart rate: an important risk factor after acute myocardial infarction / L. Reinhardt, M. Makijarvi, T. Fetsch // Cardiology. — 1996. — Vol. 87(2). — R. 104—111.
  17. Lok, N.S. Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fbrillation / N.S. Lok, C.P. Lau // Pacing. Clin. Electrophysiol. — 1998. — Vol. 21(2). — R. 386—395.
  18. Odemuyiwa, O. Comparison of the Predictive Characteristics of Heart Rate Variability Index and Left Ventricular Ejection Fraction for All-Cause Mortality, Arrhythmic Events and Sudden Death After Myocardial Infarction / O. Odemuyiwa, M. Malik, T. Farrell // Am. J. Cardiol. — 1991. — Vol. 68. — R. 434— 439.
  19. Saul, J.P. Assessment of autonomic regulation in chronic congestive heart failure by the heart rate spectral analysis / J.P. Saul , Y. Aral, R.D. Berger // Am. J. Cardiol. — 1988. — Vol. 61. — R. 1292—1299.
  20. Vandenberg, M.P. Heart rate variability in patients with atrial fbrillation is related to vagal tone / M.P. Vandenberg, J. Haaksma, J. Brouwer // Circulation. — 1997. — Vol. 19, № 96(4). — R. 1209—1216.
  21. Vikman, S. Differences in heart rate dynamics before the spontaneous onset of long and short episodes of paroxysmal atrial fbrillation / S. Vikman, S. Yli-Mayry, T.H. Makikallio // Ann. Noninvasive Electrocardiol. — 2001. — № 6(2). — R. 134— 142.
  22. Wen, Z.C. Role of autonomic tone in facilitating spontaneous onset of typical atrial futter / Z.C. Wen, S.A. Chen, C.T. Tai // J. Am. Coll. Cardiol. — 1998. — Vol. 1, № 31(3). — R. 602— 607.

 

 

PDF downloadCalcium hydroxide in the treatment of destructive forms of periodontitis with subsequent rehabilitation

V.V. Gilyazeva, A.I. Shaikhoutdinova

Abstract. The aim of the present research is to estimate the follow-up of chronic periodontitis treatment with calcium hydroxide. Forty-eight patients with destructive forms of periodontitis have been observed within 2 years. In 68% of cases after 2 years rather large periapical lesion showing complete regeneration, in 32% determined by X-ray is only a slight reduction in the size of the hearth.

Key words: periodontitis, calcium hydroxide, root canals.

 

References

  1. Antanjan, A.A. Gidrookis' kal'cija v jendodontii, obratnaja storona monety. Kriticheskij obzor literatury / A.A. An-tanjan // Jendodontija today. — 2007. — № 1.
  2. Ivanchenko, O.N. Issledovanie jeffektivnosti lechenija hronicheskogo periodontita s pomoshh'ju antisepticheskih i kal'cijsoderzhashhih materialov / O.N. Ivanchenko, S.V. Zu¬bov, E.V. Ivanova [i dr.] // Jendodontija today. — 2009. — № 2.
  3. Lamli, F. Prakticheskaja klinicheskaja jendodontija / F. Lamli, N. Adams, F.M. Tomson. — M.: Medpress-inform, 2007.
  4. Mitronin, A.V. Principy, metody i sredstva lechenija hronicheskogo periodontita pri kompleksnoj reabilitacii pacientov / A.V. Mitronin // Klinicheskaja stomatologija. — 2005. —№ 6. — S. 67—71.
  5. Pyzh'janova, M.N. Sovremennyj vzgljad na ocenku kachestva i rezul'tativnost' lechenija hronicheskogo periodontita / M.N. Pyzh'janova, A.M. Solov'eva // Jendodontija. — 2004. — № 1—2. —S. 6—7.
  6. Homenko, L.A. Prakticheskaja jendodontija / L.A. Homenko, N.M. Bidenko. — M.: Kniga pljus, 2002.

 

 

PDF downloadVasoactive function of endothelium in patients with copd and opportunities of its medicamental correction

N.A. Kоuzоubova, A.Yu. Gichkin, V.E. Perley

Abstract. A chronic obstructive pulmonary disease (COPD) is one of the important problems of public health services. However, data on a functional activity of endothelium and infuence of anti-infammatory therapy on endothelial dysfunction at COPD patients are presented insuffciently. The aim of the present study was the determination of infuence of anti-infammatory treatment on endothelial function (endothelin-1 level and results of Celermajer manoeuvre) in 90 severe and moderate COPD patients. The system endothelium dysfunction was found in 60% of patients. The degree of endothelial dysfunction was decreased after anti-infammatory treatment.

Key words: chronic obstructive pulmonary disease, beclomethazone, fenspiride, endothelial dysfunction, endothelin-1.

 

References

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. The updated 2008 report is available on www.goldcopd. com
  2. Disfunkcija jendotelija. Prichiny, mehanizmy, farmako¬logicheskaja korrekcija / pod red. N.N. Petrishheva. — SPb.: Izd-vo SPbGMU, 2003. — 184 s.
  3. Wright, J.L. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment / J.L. Wright, R.D. Levy, A. Churg // Thorax. — 2005. — Vol. 60. — R. 605—609.
  4. Jeffery, P.K. Remodeling in asthma and COPD / P.K. Jeffery // Am. J. Respire. Crit. Care. — 2001. — Vol. 164. — R. 28—38.
  5. Karoli, N.A. Rol' jendotelija v razvitii legochnoj giperten-zii u bol'nyh s hronicheskimi obstruktivnymi boleznjami legkih / N.A. Karoli, A.P. Rebrov // Klinicheskaja medici¬na. — 2004. — T. 82, № 8. — S. 8—14.
  6. Kunicina, Ju.L. Protivovospalitel'naja terapija bol'¬nyh pri hronicheskoj obstruktivnoj bolezni legkih / Ju.L. Kunicina, E.I. Shmelev // Pul'monologija. — 2003. — № 2. —S. 111—116.
  7. Shmelev, E.I. Hronicheskaja obstruktivnaja bolezn' legkih. Klinicheskie rekomendacii / E.I. Shmelev; pod red. A.G. Chu-chalina. — 2003. — S. 117—122.
  8. Chuchalin, A.G. Jeffektivnost' fenspirida u bol'nyh hro¬nicheskoj obstruktivnoj bolezn'ju legkih / A.G. Chuchalin, E.I. Shmelev, S.I. Ovcharenko [i dr.] // Consilium medicum. — 2005. — T. 7, № 10. — S. 857—863.
  9. Barnes, P.J. Targeting the Epigenome in the Treatment of Asthma and Chronic Obstructive Pulmonary Disease / P.J. Barnes // Proc. Am. Thorac. Soc. — 2009. — № 6 (8). — R. 693—696.
  10. Kuzubova, N.A. Patofiziologicheskie mehanizmy formiro¬vanija hronicheskoj obstruktivnoj bolezni legkih (kliniko-jeksperimental'noe issledovanie): avtoref. dis. … d-ra med. nauk / N.A. Kuzubova. — SPb., 2009. — 39 s.
  11. Singh, J.M. Corticosteroid therapy for patients with exacerbations of chronic obstructive pulmonary disease: a systematic review / J.M. Singh, V.A. Palda [et al.] // Arch. Intern. Med. — 2005. — Vol. 162. — R. 2527—2536.
  12. Lirsac, B. Evaluation and symptomatic treatment of surinfections exacerbations of COPD: preliminary study of antibiotic treatment combined with fenspiride (Pneumorel 80 mg) versus placebo / B. Lirsac, O. Benezet, E. Dansin [et al.] // Rev. Pneumol. Clin. — 2002. — Vol. 56. — R. 17—24.
  13. Celermajer, D.S. Non-invasive detection of endothelial dysfunction children and adults at risk of atherosclerosis / D.S. Celermajer, K.E. Sorensen, V.M. Gooch [et al.] // Lancet. — 1992. — Vol. 340 (8828). — R. 1111—1115.
  14. Corretti, M.C. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery / M.C. Corretti, T.J. Anderson, E.J. Benjamin [et al.] // J. Am. Coll. Cardiol. — 2002. — Vol. 39. — R. 257—265.
  15. Roland, M. Sputum and plasma endothelin-1 levels in exacerbation of chronic obstructive pulmonary disease / M. Roland, A. Bhowmik, R. Sapford [et al.] // Thorax. — 2001. — Vol. 56. — R. 30—35.

 

PDF downloadNeurovegetatic regulation of cardiorespiratory functional system at patients with bronchial asthma

V.N. Marchenko, V.I. Trofimov, V.A. Alexandrin, G.B. Fedoseyev

Abstract. Neurovegetatic regulation of cardiorespiratory system was estimated at 320 patients with bronchial asthma (BA) and 250 healthy persons. Parameters of heart rhythm variability were analyzed. The decrease of parameters of variability of heart rhythm at patients with BА was established at all ranges of a spectrum of heart rhythm fuctuations. These changes increased with severity of disease and activity of infammatory process in bronchi and depended on age and sex of patients. The heterogeneity of patients with BА was proved based on the initial vegetative tonus in heart rhythm regulation. Interrelations of sympathetic and parasympathetic contours of heart rhythm regulation carry sinergic character. The active role of variability of heart rhythm is proved in BA pathogenesis.

Key words: bronchial asthma, variability of heart rhythm, neurovegetatic regulation, cardiorespiratory pattern.

 

References

  1. Aleksandrin, V.A. Vegetativnaja reguljacija dyhatel'noj i serdechno-sosudistoj sistem u bol'nyh bronhial'noj astmoj: avtoref. dis. … kand. med. nauk / V.A. Aleksand-rin. — SPb., 2003. — 16 s.
  2. Babunc, I.V. Azbuka analiza variabel'nosti serdechnogo ritma / I.V. Babunc, Je.M. Miridzhanjan, Ju.A. Mashaek. — Stavropol', 2002. — 112 s.
  3. Variabel'nost' serdechnogo ritma (standarty izmerenija, fiziologicheskoj interpretacii i klinicheskogo ispol'zo¬vanija). — SPb., 2000. — 65 s.
  4. Global'naja strategija lechenija i profilaktiki bronhial'¬noj astmy / pod red. A.G. Chuchalina. — M.: Izd-vo «Atmos¬fera», 2002. — 160 s.
  5. Zulkarneev, R. H. Diagnosticheskoe znachenie ocenki va¬riabel'nosti kardiorespiratornogo patterna u bol'nyh bronhial'noj astmoj: avtoref. dis. … kand. med. nauk / R.H. Zulkarneev. — Ufa, 1997. — 24 s.
  6. Marchenko, V.N. Mehanizmy nejrovegetativnoj reguljacii kardiorespiratornoj sistemy u bol'nyh bronhial'noj astmoj i puti korrekcii vyjavlennyh narushenij: avtoref. … d-ra med. nauk / V.N. Marchenko. — SPb.: Izd-vo «NIIH SPbGU», 2004. — 38 s.
  7. Parcernjak, S.A. Stress. Vegetozy. Psihosomatika / S.A. Parcernjak. — SPb.: A.V.K., 2002. — 384 s.
  8. Sudakov, K.V. Funkcional'nye sistemy: principy dinami¬cheskoj organizacii, postulaty obshhej teorii / K.V. Sudakov // Patologicheskaja fiziologija. — 1988. — № 4. — S. 10—22

 

PDF downloadInterstitial lung diseases in pulmonological and rheumatological hospitalized patients

A.P. Rebrov, E.Yu. Ponomareva, E.E. Arkhangelskaya

Abstract. We have studied the features and correlations between clinical, morphological and rhoentgenological signs of interstitial lung diseases in pulmonological and rheumatological patients.

Key words: interstitial lung diseases, «groundglass», pulmonary fbrosis.

 

References

  1. Intersticial'nye bolezni legkih: prakticheskoe rukovod¬stvo / E.A. Kogan, B.M. Kornev, E.N. Popova, V.V. Fomin [i dr.]; pod red. N.A. Muhina. — M.: Litera, 2007. — 432 s.
  2. American Thoracic Society; European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias // Am.J.Respir.Crit.Care Med. — 2002. — Vol. 165 (2). — R. 277—304.
  3. Rejnolds, G. Intersticial'nye zabolevanija legkih / G. Rejnolds // Vnutrennie bolezni po T.R. Harrisonu. — M., 2005. — Kn. 4.
  4. Nespecificheskaja intersticial'naja pnevmonija / S.N. Av¬deev, O.E. Avdeeva // Atmosfera. Pul'monologija i aller¬gologija. — 2007. — № 4. — S. 2—6.
  5. CT Features of Lung Disease in Patients with Systemic Sclerosis: Comparison with Idiopathic Pulmonary Fibrosis and Nonspecifc Interstitial Pneumonia / S.R. Desai, S. Veeraraghavan, D.M. Hansell [et al.] // Radiology. — 2004. — Vol. 232. — R. 560—567.
  6. High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis. Diagnosis and Prognosis / D.A. Lynch, J.D. Godwin, Sh. Safrin [et al.] // Am. J. Respir. Crit. Care Med. — 2005. — Vol. 172. — R. 488—493.
  7. Chronic Hypersensitivity Pneumonitis: Differentiation from Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia by Using Thin-Section CT / C.I.S. Silva, N.L. M'ller, D.A. Lynch // Radiology. — 2008. — Vol. 246. — R. 288— 297.
  8. The Relationship between Individual Histologic Features and Disease Progression in Idiopathic Pulmonary Fibrosis / A.G. Nicholson, L.G. Fulford, T.V. Colby [et al.] // Am. J. Respir. Crit. Care Med. — 2002. — Vol. 166. — R. 173—177.
  9. Cytokine profle of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia / F. Meloni, R. Caporali, A. Marone Bianco [et al.] // Ann. Rheum. Dis. — 2004. — Vol. 63. — R. 892—894.
  10. Frognier, R. Women and interstitial lung diseases / R. Frognier, V. Cottin, J.-F. Cordier // Eur. Respir. Mon. — 2003. — Vol. 25. — R. 167—189.
  11. Grutters, J.C. Genetics of fbrosing lung diseases / J.C. Grutters, R.M. Du Bois // Eur. Respir. J. — 2005. — Vol. 25. — R. 915— 927.
  12. Predictors of end stage lung disease in a cohort of patients with scleroderma / C. Morgan, C. Knight, M. Lunt [et al.] // Ann. Rheum. Dis. — 2003. — Vol. 62. — R. 146—150.
  13. Pulmonary involvement in diffuse cutaneous sclerosis: bronchoalveolar fuid granulocytosis predicts progression of fbrosing alveolitis / C. Witt, A.C. Borges, M. John [et al.] // Ann. Rheum. Dis. — 1999. — Vol. 58. — R. 635—640.
  14. Classifcation and natural history of the idiopathic interstitial pneumonias / Dong Soon Kim, H.R. Collard, T.E. King [et al.] // The Proceedings of the American Thoracic Society. — 2006. — № 3. — R. 285—292.
  15. Clinical signifcance of histological classifcation of idiopathic interstitial pneumonia / K.R. Flaherty, G.B. Toews, W.D. Travis // Eur. Respir. J. — 2002. — Vol. 19. — R. 275—283.
  16. Idiopathic Pulmonary Fibrosis. Predicting Response to Therapy and Survival / S.E. Gay, E.A. Kazerooni, G.B. Toews // Am. J. Respir. Crit. Care Med. — 1998. — Vol. 157 (4). — R. 1063—1072.

 

PDF downloadThe evolution of the functional tests in patients with chronic obstructive pulmonary disease three months after comprehensive vaccination against pneumococcus, haemophilus influenzae type b and influenza

A.D. Protasov, A.V. Zhestkov, M.P. Kostinov, A.A. Ryzhov

Abstract. The article presents analysis of respiratory function and test with a six-minute walking in patients with chronic obstructive pulmonary disease (COPD) in 3 months after complete vaccination against pneumococcus, H. infuenzae type b and infuenza compared with unvaccinated patients with COPD. 1 group — 48 patients with COPD, vaccinated simultaneously «Pneumo-23», «Hiberiх», «Grippol plus» (mean age — 61,46±1,17 years). Group 2 — 80 non-vaccinated patients with COPD (mean age 54,65±0,6 years). In 3 months after complete vaccination in patients with COPD noted positive dynamics in terms of forced vital capacity at 2-nd and 4-th stages of COPD, forced expiratory volume in the frst second with 2-nd, 3-rd, 4-th stage, a test with six-minute walking at 1-st, 2-nd, 3-rd stages of COPD.

Key words: vaccination, chronic obstructive lung disease.

 

References

  1. Velichkovskij, B.T. O putjah «sberezhenija naroda» i roli boleznej organov dyhanija v reshenii jetoj problemy / B.T. Velichkovskij // Pul'monologija. — 2007. — № 3. —      6. S. 5—9.
  2. Haitov, M.R. Rol' respiratornyh virusov v techenii hroni­cheskih obstruktivnyh zabolevanij respiratornogo trakta      7. / M.R. Haitov, V.S. Akimov // Rossijskij respiratornyj zhurnal. — 2005. — № 6. — S. 65—69.
  3. Chuchalin, A.G. Belaja kniga. Pul'monologija / A.G. Chuchalin. — M.: Medicina, 2004. — S. 7—34.
  4. Chuchalin, A.G. Hronicheskaja obstruktivnaja bolezn' legkih: monografija / A.G. Chuchalin. — M.: Izdatel'skij dom «At­mosfera», 2008. — C. 217—221.
  5. Buist, S. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study / S. Buist, McBurnie, W.M. Vollmer [et al.] // Lancet. — 2007. — Vol. 370. — P. 741—750.
  6. Mannino, D.M. Global burden of COPD: risk factors, prevalence, and future trends / D.M. Mannino, A.S. Buist // Lancet. — 2007. — Vol. 370. — P. 765—773.
  7. Chuchalin, A.G. Klinicheskie rekomendacii po hronicheskoj obstruktivnoj bolezni legkih / A.G. Chuchalin. — M., 2007. — 240 s.

 

REVIEWS

PDF downloadUp-to-date standarts of eradication therapy. Аre all the questions answered?

R.A. Abdoulkhakov, S.R. Abdoulkhakov

Abstract. H.pylori detection methods, available eradication schemes as well as the reasons of low effcacy of eradication therapy are reviewed in the article. Possible options for frst-line therapy, schemes used for the second- and third line therapies in case of failure of frst line eradication therapy are discussed.

Key words: H.pylori, detection methods, eradication therapy, eradication rate.

References

  1. Cutler, A.F. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection / A.F. Cutler, S. Havstad, C.K. Ma [et al.] // Gastroenterology. — 1995. — Vol. 109. — Р. 136—141.
  2. Thijs, J.C. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard / J.C. Thijs, A.A. van Zwet, W.J. Thijs [et al.] // Am. J. Gastroenterol. — 1996. — Vol. 91. — Р. 2125— 2129.
  3. Malfertheiner, P. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report / P. Malfertheiner, F. Megraud, C. O’Morain [et al.] // Gut. — 2007. — Vol. 56. — Р. 772—781.
  4. Kearney, D.J. Treatment of Helicobacter pylori infection in clinical practice in the United States / D.J. Kearney, A. Brousal // Dig Dis Sci. — 2000. — Vol. 45. — Р. 265—271.
  5. Saad, R.J. Treatment of Helicobacter pylori infection in 2006 / R.J. Saad, W.D. Chey // Gastroenterol. Hepatol. Ann. Rev. — 2006. —№ 1. — Р. 30—35.
  6. Kadayifci, A. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years / A. Kadayifci, H. Buyukhatipoglu, M. Cemil Savas, I. Simsek // Clin. Ther. — 2006. — Vol. 28. — Р. 1960—1966.
  7. Me´graud, F.H. Н.pylori antibiotic resistance: prevalence, importance, and advances in testing / F.H. Meґgraud // Gut. — 2004. — Vol. 53. — Р. 1374—1384.
  8. Romano, M. Failure of frst-line eradication treatment signifcantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates / M. Romano, M.R. Iovene, M.I. Russo [et al.] // J. Clin. Pathol. — 2008. — Vol. 61. — Р. 1112—1115.
  9. Boyanova, L. Prevlance of multidrug-resistant Helicobacter pylori in Bulgaria / L. Boyanova // J. Med. Microbiol. — 2009. — Vol. 58(рt. 7). — Р. 930—935.
  10. De Francesco, V. Furazolidone therapy for Helicobacter pylori: is it effective and safe? / V. de Francesco, E. Ierardi, C. Hassan, A. Zullo // World J. Gastroenterol. — 2009. — Vol. 21. — Р. 15.
  11. Chisholm, S.A. Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000—2005) / S.A. Chisholm, E.L. Teare, K. Davies, R.J. Owen // Euro Surveill. — 2007. — Vol. 12. — Р. E3—Е4.
  12. Osato, M.S. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States / M.S. Osato, R. Reddy, S.G. Reddy [et al.] // Arch. Intern. Med. — 2001. — Vol. 161. — Р. 1217.
  13. Calvet, X. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection / X. Calvet, N. Garcıґa, T. Loґpez [et al.] // Aliment. Pharmacol. Ther. — 2000. — Vol. 14. — Р. 603—609.
  14. Chey, W.D. American College of Gastroenterology guideline on the management of Helicobacter pylori infection / W.D. Chey, B.C. Wong // Am. J. Gastroenterol. — 2007. — Vol. 102. — Р. 1808—1825.
  15. Zullo, A. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis / A. Zullo, V. de Francesco [et al.] // Gut. — 2007. — Vol. 56. — Р. 1353—1357.
  16. Fischbach. S3 guideline on Helicobacter pylori and gastroduodenal ulcer disease of the German Society for Digestive and Metabolic Diseases (Deutsche Gesellschaft fьr Verdauungs- und Stoffwechselkrankheiten, DGVS) / Fischbach [et al.] // Z. Gastroenterol. — 2009. — Vol. 47. — Р. 68—102.
  17. Gisbert, J.P. Rescue regimens after Helicobacter pylori treatment failure / J.P. Gisbert // World J. Gastroenterol. — 2008. — Vol. 21. — Р. 14.
  18. O’Connor, A. Treatment of Helicobacter pylori infection / A. O’Connor, J. Gisbert, C. O’Morain // Helicobacter. — 2009. — Vol. 14. — P. 46—51.
  19. Suzuki, S. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori / S. Suzuki, H. Suzuki, T. Nishizawa [et al.] // Digestion. — 2009. — Vol. 79. — Р. 1—4.
  20. Tankovic, J. Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fuoroquinolone resistance in Helicobacter pylori / J. Tankovic, C. Lascols, Q. Sculo [et al.] // Antimicrob Agents Chemother. — 2003. — Vol. 47. — Р. 3942—3944.
  21. Glocker, E. Quinolone resistance in Helicobacter pylori isolates in Germany / E. Glocker, H.P. Stueger, M. Kist // Antimicrob Agents Chemother. — 2007. — Vol. 51. — Р. 346— 349.
  22. Vakil, N. Sequential therapy for Helicobacter pylori: time to consider making the switch? / N. Vakil, D. Vaira // JAMA. — 2008. — Vol. 17. — Р. 300.
  23. Tong, J.L. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis / J.L. Tong, Z.H. Ran, J. Shen, S.D. Xiao // J. Clin. Pharm. Ther. — 2009. — Vol. 34. — Р. 41—53.
  24. Essa, A.S. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing «concomitant therapy» versus triple therapy for Helicobacter pylori eradication / A.S. Essa, J.R. Kramer, D.Y. Graham, G. Treiber // Helicobacter. — 2009. — Vol. 14. — Р. 109—118.

 

LECTURES

PDF downloadTubulointerstitial nephritis

O.N. Sigitova, E.V. Arkhipov

Abstract. The article deals with modern views on etiology, classifcation, clinical features, approaches to diagnosis and treatment principles of tubulointerstitial nephritis, based on the results of international controlled trials.

Key words: tubulointerstitial nephritis.

 

References

  1. Muther, R.S. Renal manifestations of sarcoidosis / R.S. Muther, D.A. McCarron, W.M. Bennett // Arch. Intern. Med. — 1981. — Vol. 141. — P. 643—645.
  2. Lofgren, S. Renal complications in sarcoidosis; functional and biopsy studies / S. Lofgren, B. Snellman, A.H. Lindgren // Acta. Med. Scand. — 1957. — Vol. 295. — P.305—308.
  3. Gobel, U. The protean face of renal sarcoidosis / U. Gobel, R. Kettritz, W. Schneider, F.C. Luft // J. Am. Soc. Nephrol. — 2001. — № 12. — P. 616—623.
  4. Utas, C. Granulomatous interstitial nephritis in extrapulmonary sarcoidosis / C. Utas, A. Dogukan, T.E. Patiroglu [et al.] // Clin. Nephrol. — 1999. — Vol. 51. — P. 252—254.
  5. Pinter, I. Analgesic nephropathy in Hungary: the HANS study // I. Pinter, J. Matyus, Z. Czegany [et al.] // Nephrol. Dial. Transplant. — 2004. — Vol. 19. — P. 840—843.
  6. Ransford, R.A.J. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines / R.A.J. Ransford, M.J.S. Langman // Gut. — 2002. — Vol. 51. — P. 536—539.
  7. Bossini, N. Clinical and morphological features of kidney involvement in primary Sjogren's syndrome / N. Bossini, S. Savoldi, F. Franceschini [et al.] // Nephrol. Dial. Transplant. — 2001. — Vol. 16. — P. 2328—2332.
  8. Bikbov, B.T. O sostojanii zamestitel'noj pochechnoj terapii bol'nyh s hronicheskoj pochechnoj nedostatochnost'ju v Ros¬sijskoj Federacii v 2001 g. (otchet po dannym registra Ros¬sijskogo dializnogo obshhestva) / B.T. Bikbov, N.A. Tomilina // Nefrologija i dializ. — 2004. — № 6(1). — P. 4—42.
  9. Sessa, A. Acute renal failure due to idiopathic tubulo-intestinal nephritis and uveitis: «TINU syndrome». Case report and review of the literature / A. Sessa, M. Meroni, G. Battini [et al.] // J. Nephrol. — 2000. — Vol. 13. — P. 377—380.
  10. Pommer, W. The analgesic problem in the Federal Republic of Germany: analgesic consumption, frequency of analgesic nephropathy and regional differences / W. Pommer, G. Glaeske, M. Molzahn // Clin. Nephrol. — 1986. — Vol. 26. — P. 273— 278.
  11. Matousovic, K. Incidence of analgesic nephropathy among patients undergoing renal replacement therapy in the Czech republic and Slovak republic / K. Matousovic, M.M. Elseviers, D. Devecka [et al.] // Nephrol. Dial. Transplant. — 1996. — Vol. 11. — P. 1048—1051.
  12. Bergner, R. Frequency of kidney disease in chronic sarcoidosis / R. Bergner, M. Hoffmann, R. Waldherr, M. Uppenkamp // Sarcoidosis Vasc. Diffuse Lung Dis. — 2003. — Vol. 20. — P. 126—132.
  13. Weber, M. Ultrasonic findings in analgesic nephropathy / M. Weber, B. Braun, H. Kohler // Nephron. — 1985. — Vol. 39. — P. 216—222.
  14. Elseviers, M.M. High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure / M.M. Elseviers, M.E. De Broe // Kidney Int. — 1995. — Vol. 48. — P. 1316—1323.
  15. Brause, M. Renal involvement in sarcoidosis — a report of 6 cases / M. Brause, K. Magnusson, S. Degenhardt [et al.] // Clin. Nephrol. — 2002. — Vol. 57. — P. 142—148.
  16. Clarkson, M.R. Acute interstitial nephritis: clinical features and response to corticosteroid therapy / M.R. Clarkson, L. Giblin, F.P. O’Connell [et al.] // Nephrol. Dial. Transplant. — 2004. — Vol. 19. — P. 2778—2783.
  17. Thumfart, J. Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy / J. Thumfart, D. Muller, B. Rudolph [et al.] // Am. J. Kidney Dis. — 2005. — Vol.45. — P. 411—414.
  18. Locatelli, F. Long-term progression of chronic renal insuffciency in the AIPRI Extension Study / F. Locatelli, I. Carbans, G. Maschio [et al.] // Kidney Int. — 1997. — Vol. 52 (suppl. 63). — P. 63— 66.
  19. The Gisen Group Randomised placebo-controlled trial of effect of ramipril on decline in glomerular fltration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy // Lancet. — 1997. — Vol. 349. — P. 1857—1863.
  20. Ruggenenti, P. Renoprotective properties of ACE-inhibitors in non-diabetic nephropathies with non-nephrotic proteinuria / P. Ruggenenti, A. Perna, G. Gherardi [et al.] // Lancet. — 1999. — Vol.354. — P. 359—364.
  21. Brenner, B.M. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy / B.M. Brenner, M.E. Cooper, D. de Zeeuw [et al.] // N. Engl. J. Med. — 2001. — Vol. 345. — P. 861—869.
  22. Lewis, E.J. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes / E.J. Lewis, L.G. Hunsicker, W.R. Clarke [et al.] // N. Engl. J. Med. — 2001. — Vol. 345. — P. 851—860.
  23. Maschio, G. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insuffciency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insuffciency Study Group / G. Maschio, D. Alberti, G. Janin [et al.] // N. Engl. J. Med. — 1996. — Vol. 334. — P. 939—945.
  24. Jafar, T.H. Angiotensin-conveting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data / T.H. Jafar, C.H. Schmid, M. Landa [et al.] // Ann. Intern. Med. — 2001. — Vol. 135. — P. 73—87.

 

BRIEF ARTICLES

PDF downloadExperience of combined (with roentgenotherapy) treatment of lymphorrhea in the groin after arterial reconstruction

I.I. Kamalov, I.V. Gоulyayeva, R.R. Akhmadeyev

Abstract. The complication after reconstructive operations on the vessels in the femoral triangle is lymphorrhea, which considerably increases the length of patient's hospital stay. Roentgenotherapy with the use of light irradiation stops outfow of lymph (lymphorrhea) from postoperative wounds and makes their healing rapid.

Key words: postoperative lymphorrhea, roentgenotherapy.

 

References

  1. Kishkovskij, A.N. Luchevaja terapija neopuholevyh zabole¬vanij / A.N. Kishkovskij, A.L. Dudarev. — M.: Medicina, 1977. — S. 17, 32—35, 109.
  2. Central'nyj nauchno-issledovatel'skij rentgeno-ra-diologicheskij institut MZ SSSR: metod. rekomendacii po luchevoj terapii neopuholevyh zabolevanij. — L., 1989.
  3. Fokin, A.A. Luchevoe lechenie limforei v pahovoj oblasti posle arterial'noj rekonstrukcii / A.A. Fokin, A.G. Kuzne¬cov, L.A. Orehova, A.A. Fedin // Angiologija i sosudistaja hirurgija. — 2001.

 

FOR GENERAL PRACTITIONER

PDF downloadDepression and female health

N.S. Volchkova, S.F. Soubchankoulova, A.F. Soubchankoulova

Abstract. In the given article the basic data on patogenesys, clinic and treatment of depressions at women during the
various periods of life are refected.

Key words: depression, female health, pubertat, climakterik period.

 

References

  1. Aleksandrovskij, Ju.A. Psihicheskie rasstrojstva v obshhe¬medicinskoj praktike i ih lechenie / Ju.A. Aleksandrov¬skij. — M.: GJeOTAR-MED, 2004. — S. 63—97.
  2. Aleksandrovskij, Ju.A. Pogranichnye psihicheskie rasstroj¬stva: rukovodstvo dlja vrachej / Ju.A. Aleksandrovskij. —M.: GJeOTAR-Media, 2007. — S. 241—262.
  3. Dubnickaja, Je.G. Problemy kliniki i terapii depressij, svjazannyh s reproduktivnym ciklom zhenshhin / Je.G. Dub-nickaja // Consilium medicum. — 2008. — T. 10, № 6. — S. 87—90.
  4. Ajlamazjan, Je.K. Akusherstvo: nacional'noe rukovodstvo / Je.K. Ajlamazjan; pod red. Je.K. Ajlamazjana, V.I. Kulakova, V.E. Radzinskogo, G.M. Savel'evoj. — M.: GJeOTAR-Media, 2007. — S. 668—674.
  5. Karpov, A.M. Samozashhita ot samorazrushenija / A.M. Kar¬pov. — M.: Medpress, 2005. — S. 60—84.
  6. Smulevich, A.B. Depressii v obshhej medicine: rukovodstvo dlja vrachej / A.B. Smulevich. — M., 2007. — 256 s.
  7. Makolkin, V.I. Psihosomaticheskie rasstrojstva v klini¬ke vnutrennih boleznej: ucheb. posobie / V.I. Makolkin, L.V. Romasenko. — M., 2003. — 24 s.
  8. Voznesenskaja, T.G. Nevroticheskaja depressija v obshhemedi¬cinskoj praktike. Pozicija nevrologa / T.G. Voznesenskaja // Farmateka. — 2009. — № 10 (184). — S. 70—75.
  9. Tjuvina, N.A. Depressija u zhenshhin: metod. rekomendacii / N.A. Tjuvina. — M., 2008. — 28 s.
  10. Nabiullina, R. R. Pogranichnye psihicheskie rasstrojstva u somaticheskih bol'nyh: klinika, diagnostika, lechenie: poso¬bie dlja vrachej / R. R. Nabiullina. — Kazan', 2005. — 28 s.
  11. Nikishova, M.B. Depressii i nevrozy v obshhemedicinskoj praktike / M.B. Nikishova. — M., 2008. — 136 s.

 

CLINICAL CASE

PDF downloadClinical case of the severe flu at the pregnant woman, complicated by pneumonia development

R.P. Gouslyakova, I.R. Galimova, A.A. Vizel, I.G. Salikhov, A.A. Hasanov, V.I. Ilyinskiy, A.A. Vanyushin, P.V. Ilyin, A.G. Skripina

Abstract. The case of a severe current of the fu, complicated by a severe pneumonia at the young pregnant woman with a favorable outcome for mother and the child is described. Problems of a fu, a pneumonia and pregnancy are discussed.

Key words: a fu, a pneumonia, pregnancy.

 

References

  1. Shuvalova, E.P. Infekcionnye bolezni: uchebnik / E.P. Shu¬valova. — 2-e izd., pererab. i dop. — M.: Medicina, 1982. — S. 167—178.
  2. Anohin, V.A. Diagnostika i lechenie detskih infekcionnyh zabolevanij: ucheb. posobie dlja studentov / V.A. Anohin, G.R. Hasanova, L.M. Malysheva [i dr.]. — Kazan': KGMU, 2006. — S. 10—17.
  3. Jamieson, D.J. H1N1 2009 infuenza virus infection during pregnancy in the USA / D.J. Jamieson, M.A. Honein, S.A. Rasmussen [et al.] // Lancet. — 2009. — Vol. 374. — R. 451—458.
  4. Mangtani, P. Pandemic H1N1 infection in pregnant women in the USA / P. Mangtani, T.K. Mak, D. Pfeifer // Lancet. — 2009. — Vol. 374. — R. 429—430.
  5. Vizel', A.A. Gripp: ot opredelenija k lecheniju / A.A. Vizel' // Prakticheskaja medicina. — 2010. — № 1 (40). — S. 172— 175.
  6. Vizel', A.A. Opyt raboty v ochage zabolevanija grippom A (H1/N1) tjazhelogo techenija. Normativno-pravovye i spra¬vochnye materialy / A.A. Vizel', V.A. Anohin, A.A. Hasanov [i dr.] // Medicinskij informacionnyj vestnik (pril. k zhurnalu, Samara). — 2009. — Vyp. 13. — S. 12—31.
  7. Skvorcova, V.I. Gripp A/H1N1 i vyzvannaja im pnevmonija u beremennyh. Jetiotropnaja i respiratornaja terapija: inform. pis'mo ot 28 nojabrja 2009 g. № 24-5/10/2-9533.
  8. Farrahov, A.Z. Pervyj opyt raboty s pandemicheskim grippom tjazhelogo techenija, oslozhnennym pnevmoniej / A.Z. Farrahov, R.K. Golubeva, A.A. Vizel' [i dr.] // Vestnik sovremennoj klinicheskoj mediciny. — 2009. — T. 2, № 4. — S. 4—11.

 

PDF downloadClinical case of follow-up of patient with gout and metabolic syndrome

V.B. Zakirova, G.S. Galyautdinov, E.V. Skryabina, A.N. Gaifoullina, A.I. Gainetdinov

Abstract. Clinical case of modern course of gout in combination with metabolic syndrome is presented.

Key words: gout, metabolic syndrome, diagnostics.

 

References

  1. Barskova, V.G. Podagra i sindrom insulinorezistentnosti / V.G. Barskova, V.A. Nasonova // Russkij medicinskij zhur¬nal. — 2003. — № 12, 23.
  2. Maksudova, A.N. Podagra / A.N. Maksudova, I.G. Salihov, R.A. Habirov. — M.: MEDpress-inform, 2008. — S. 96.
  3. Nasonova, E.L. Revmatologija: nacional'noe rukovodstvo / E.L. Nasonova, V.A. Nasonova. — M.: GEOTAR-Media, 2008. — S. 372—380.
  4. Gaffo, A.L. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? / A.L. Gaffo, N.L. Edwards, K.G. Saag Gout // Arthritis Research & Therapy. — 2009. — Vol. 11, issue 4. — P. 240—249.
  5. Arromdee, E. Epidemiology of Gout: Is the Incidence Rising? / E. Arromdee, C.J. Michet, C.S. Crowson [et al.] // J. Rheumatol. — 2002. — Vol. 29. — P. 2403—2406.
  6. Dessein, P.H. Dislipidemia and insulin resistance in gout: suffciently common to be considered in the evaluation and management of every patient / P.H. Dessein, A.E. Stanwix, E.A. Shipton, B.I. Joffe // III African League Against Rheumatism (AFLAR) Conference. — 1999.
  7. Hyon, K. Prevalence of the Metabolic Syndrome in Patients With Gout: The Third National Health and Nutrition Examination Survey / K. Hyon, S. Ford [et al.] // Arthritis & Rheumatism. — 2007. — Vol. 57. — № 1. — R. 109—115.
  8. Rho, Y.H. The prevalence of metabolic syndrome in patients with gout: a multicenter study / Y.H. Rho, S.J. Choi, Y.H. Lee [et al.]// J. Korean. Med. Sci. — 2005. — Vol. 20, issue 6. — R. 1029—1033.
  9. Takahashi, S. Increased visceral fat accomulation further aggravates the risk of insulin resistance in gout / S. Takahashi, Y. Moriwaki, Z. Tsutsumi [et al.] // Metabolism. — 2001. — Vol.50, issue 4. — R. 393—398.
  10. Teh-Ling, L. Is Hyperuricemia Another Facet of the Metabolic Syndrome? / L. Teh-Ling, L. Ming-Wei, H. Li-Chuan [et al.] // J. Chin. Med. Assoc. — 2006. — Vol. 69, № 3. — R. 104— 109.

 

PDF downloadAugmentation mammoplasty

S.A. Obydennov

Abstract. Results of the augmentation of the breast in 240 patients, using different approaches were analyzed. Augmentation — this is augmentation of the breast with implants. Now in plastic surgery augmentation mammaplasty is not a diffcult operation. Contemporary methods allow conducfng the augmentation of the breast quickly.

Key words: augmentation mammaplasty, breast, implants.

 

References

  1. Ismagilov, A.H. Tranaksilljarnaja subpektoral'naja augmen-tacionnaja mammoplastika s vidioassistenciej/ A.H. Is-magilov, R.Sh. Hasanov, H.M. Gubajdullin, A.M. Gimranov
  2. // Annaly plasticheskoj, rekonstruktivnoj i jesteticheskoj hirurgii. — 2008. — T.3 (pril.). — S. 179—180.
  3. Belousov, A.E. Plasticheskaja rekonstruktivnaja i jestetiche¬skaja hirurgija / A.E. Belousov. —SPb., 1998.
  4. Jenny, H. Areolar approach to augmentation mammaplasty/ H. Jenny // Plast. Reconsr. Surg. — 1974. — Vol. 53. — P. 344.
  5. Jones, F.R. A periareolar incision for augmentation mammaplasty/ F.R. Jones, A.P. Tauruas // Plast. Reconsr. Surg. — 1973. — Vol. 51. — P. 641.
  6. Spear, S.L.The medial periareolar approach to submuscular augmentation mammaplasty under local anaesthesia / S.L. Spear, H. Matsuba, J.W. Little // Plast. Reconsr. Surg. — 1989. — Vol. 84. — P. 399.
  7. Candiani, P. Augmentation mammaplasty: Personal evolution on the concept looking for an ideal technigue / P. Candiani, G.L. Capiglio // Aesthetic plast. Surg. — 1997. — Vol. 21. — P. 417—422.
  8. Hidalgo, D.A. Breast augmentation: Choosing the optimal incision, implant and pocket plane/ D.A. Hidalgo // Plast. Reconsr. Surg. — 2000 — Vol. 105. — P. 2002.
  9. Courtiss, E.H. Breast sensation before and after plastic surgery / E.H. Courtiss, R.M. Goldvin // Plast. Reconsr. Surg. — 1979. — Vol. 58. — P. 1.
  10. Stoff-Khalili, M.A. Subfascial periareolar augmentation mammaplasty / M.A. Stoff-Khalili, R. Scholze, R.M. William // Plast. Reconsr. Surg. — 2004. — Vol. 114. — P. 1280.

 

 

PDF downloadWolff—Parkinson—White Syndrome in cardiology practice (demonstration of clinical case)

R.G. Saifoutdinov, E.V. Pak, A.R. Gilyazova, E.F. Roubanova, R.S. Nasyboullina

Abstract. In this article the clinical case of WPW syndrome, the etiology, clinical manifestation, methods of diagnosis and
treatment was presented.

Key words: the WPW syndrome, atrioventricular reciprocal tachycardia, radiofrequency catheter ablation.

 

References

  1. Ardashev, A.V. Sindrom Vol'ffa—Parkinsona—Uajta / A.V. Ardashev, M.S. Rybachenko // Kardiologija. — 2009. — № 10. — S. 77—87.
  2. Golicyn, S.P. Mercatel'naja aritmija u bol'nyh s sind¬romom Vol'ffa—Parkinsona—Uajta; jelektrofiziolo¬gicheskie mehanizmy, diagnostika, osobennosti techenija / S.P. Golicyn, S.F. Sokolov, A.A. Grossu, O.A. Mjasnikov // Terapevticheskij arhiv. — 1983. — № 11. — S. 48—52.
  3. Grossu, A.L. Radiochastotnaja kateternaja abljacija: metodika, pokazanija k provedeniju i klinicheskaja jeffektivnost' pri nadzheludochkovyh tahiaritmijah / A.L. Grossu, S.E. Curkan // Kardiologija. — 1997. — № 2. — S. 87—91.
  4. Kushakovskij, M.S. Aritmii serdca / M.S. Kushakovskij. — SPb.: Foliant, 2004. — 668 c.
  5. Orlov, V.N. Rukovodstvo po jelektrokardiografii / V.N. Or¬lov. — M., 2004. — 525 c.
  6. Gallagher, J.J. Cardiac electrophysiology and arrhythmias / J.J. Gallagher. — Orlando, 1985. — 474 p.

 

PDF downloadWegeners granulematosis (clinical case in practice)

O.N. Sigitova, E.I. Bikmoukhammetova, A.R. Bogdanova

Abstract. In the past decade the rise of systemic vasculitis. Wegener’s granulomatosis — necrotizing vasculitis of small vessels and medium-sized with the involvement of the respiratory tract and kidneys. It can occur under a variety of masks, not only in the debut, but also in the period of intensive clinical picture, making it diffcult to diagnose and affects the prognosis of life.

Key words: systemic vasculitis, Wegener’s granulomatosis, glomerulonephritis, antineytroflnye antibodies.

 

References

  1. Denisov, I.N. Spravochnik «2000 boleznej ot A do Ja» / I.N. Denisov, Ju.L. Shevchenko. — M.: GJeOTAR-MED, 2003.
  2. Mel#jankin, A.V. Legochnaja forma granulematoza Vegenera: KT i rentgenologicheskie priznaki (klinicheskoe nabljude¬nie i obzor literatury) / A.V. Mel#jankin // Medicinskaja vizualizacija. — 2002. — № 4. — S. 56—59.
  3. Nasonov, E.L. Vaskulity i vaskulopatii / E.L. Nasonov, A.A. Baranov, N.I. Shilkina — Jaroslavl': Verhnjaja Vol¬ga. — 1999. — № 9. — S. 35—37.
  4. Allen, N.B. Cyclosporin A therapy for Wegener’s granulomatosis / N.B. Allen, D.S. Caldwell, J.R. Rice [et al.] // Adv. Exp. Med. Biol. — 1993. — Vol. 336. — P. 473—476.
  5. Anderson, G. Wegener’s Granuloma. A series of 265 British cases seen between 1975 and 1985 / G. Anderson, E.T. Coles, M. Crane [et al.] // Q. J. Med. — 1992. — Vol. 83 — P. 427—438.
  6. Andrassy, K. De novo glomerulonephritis in patients during remission from Wegener’s granulomatosis / K. Andrassy, R. Waldherr, A. Erb [et al.] // Clin. Nephrol. — 1992. — Vol. 38. — P. 295—298.
  7. Briedigkeit, L. Prognostic factors in Wegener’s granulomatosis / L. Briedigkeit, R. Kettritz, U. Gobel [et al.] // Postgrad. Med. J. — 1993. — Vol. 69. — P. 856—861.
  8. Fauci, A.S. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years / A.S. Fauci, B.E. Haynes, P. Katz [et al.] // Ann. Int. Med. — 1983. — Vol. 98. — P. 76—85.
  9. Gross, W.L. Pathogenesis of Wegener’s granulomatosis / W.L. Gross, E. Csernok, A. Trabandt // Ann. Med. Int. — 1998. — Vol. 149. — P. 280—286.
  10. Harper, S.L. Wegener’s granulomatosis: The relationship Between Ocular and Systemic Disease / S.L. Harper, E. Letko, C.M. Samson [et al.] // J. Rheum. — 2001. — Vol. 28. — P. 1025—1032.
  11. Oddis, C.V. Wegener’s granulomatosis with delayed pulmonary and colonic involvement / C.V. Oddis, A.C. Schoolwerth // Abt. South. Med. J. — 1984. — Vol. 77. — P. 1589—1592.

 

MEDICINE HISTORY

PDF downloadEvolution of pediatric surgery and urology in Kazan. A.A. Akhounzyanov

Abstract. In the article dedicated to the 110th anniversary of beginning of teaching pediatric surgery in the medical faculty of Kazan Imperial University, the historical events, that promoted the development of pediatric surgery and urology as a medical specialty are described in the single text for the frst time. Stages of pediatric surgery formation, system of student’s training in pediatric surgery, contribution of famous professors surgeons, pediatricians and obstetrician to development of pediatric surgery in Kazan are covered. Results of joint researches of author and Kazan pediatric surgeons and urologists in feld of live issues of pediatric urology-andrology are described in the second part of the article. Possibility to solve a most burning pediatric urology-andrology issues, based on systematic approach and multiple-factor analysis is demonstrated. Scientifc newness and positive effect of introduced organizational, medical and medical-technical solutions are confrmed by results of long-term clinical trials in pediatric surgery and urology departments in Tatar Republic and Russian Federation, as well as by numerous of certifcates of authorship and patents for an inventions.

Key words: history of pediatric surgery, pediatric urology-andrology, obstructive uropathies.